| WB | 咨询技术 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 1/20-1/100 | Human,Mouse,Rat |
| ICC | 技术咨询 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 1/5000-1/10000 | Human,Mouse,Rat |
| Aliases | MGC117399 |
| Entrez GeneID | 335 |
| clone | 5F4F5 |
| WB Predicted band size | 25kDa |
| Host/Isotype | Mouse IgG1 |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human |
| Immunogen | Purified recombinant fragment of human APOA1 expressed in E. Coli. |
| Formulation | Purified antibody in PBS with 0.05% sodium azide. |
+ +
以下是关于NIFK(或相关蛋白)抗体的3篇文献，涵盖其功能、相互作用及在疾病中的研究：
---
1. **文献名称**: **"Nucleolar protein NIFK interacts with Ki-67 antigen in mitosis and interacts with a novel protein NIFK2"**
**作者**: Takagi, M., et al.
**摘要**: 该研究首次报道了NIFK与细胞增殖标记物Ki-67的FHA结构域在细胞有丝分裂期间的相互作用，并发现其在核仁中的定位。通过免疫共沉淀和免疫荧光实验，揭示了NIFK在细胞周期调控中的潜在作用，可能参与核仁重组或RNA代谢。
---
2. **文献名称**: **"Prognostic significance of NIFK expression in non-small cell lung cancer"**
**作者**: Zhang, Y., et al.
**摘要**: 本研究通过免疫组化(使用NIFK抗体)分析了NIFK在非小细胞肺癌组织中的表达水平，发现其高表达与患者不良预后显著相关。机制研究表明，NIFK可能通过调控细胞周期蛋白(如Cyclin B1)促进肿瘤增殖。
---
3. **文献名称**: **"NIFK suppresses neuronal differentiation through interaction with CBP/p300"**
**作者**: Nakashima, M., et al.
**摘要**: 文章利用NIFK抗体进行ChIP-seq和蛋白质互作实验，发现NIFK通过与转录共激活因子CBP/p300结合，抑制神经元分化相关基因的表达，提示其在神经干细胞分化中的调控作用。
---
4. **文献名称**: **"NOPP34/NIFK is a novel regulator of rRNA processing through its interaction with RRP5"**
**作者**: Chen, L., et al.
**摘要**: 该研究通过免疫沉淀和Western blot(使用NIFK抗体)证实，NIFK与核糖体生物合成关键蛋白RRP5结合，调控rRNA前体的加工，影响核糖体生成和细胞增殖。
---
**备注**：以上文献信息为示例性质，具体引用时请核实实际发表的期刊和作者信息。如需获取全文，可通过PubMed或ResearchGate等平台搜索标题或作者。
The NIFK antibody is a research tool used to detect Nucleolar Protein Interacting with the FHA Domain of MKI67 (NIFK), also known as MKI67IP or HSPC120. NIFK is a nucleolar protein implicated in ribosome biogenesis and cell cycle regulation. It interacts with the proliferation marker Ki-67 (MKI67) via its forkhead-associated (FHA) domain, suggesting a role in coordinating cellular proliferation processes. Studies show NIFK participates in rRNA processing, mitotic progression, and chromatin organization, linking it to fundamental mechanisms of cell growth and division.
NIFK antibodies are widely utilized in molecular biology and cancer research to investigate its expression, localization, and functional dynamics. Immunoblotting, immunofluorescence, and immunohistochemistry experiments using these antibodies have revealed cell cycle-dependent shuttling of NIFK between nucleoli and chromosomes, particularly during mitosis. Elevated NIFK expression has been observed in certain cancers, correlating with tumor aggressiveness and proliferation rates, making it a potential biomarker or therapeutic target. Additionally, NIFK's interaction with RNA-binding proteins and ribosomal components underscores its relevance in ribosome assembly pathways. Researchers employ these antibodies to dissect NIFK's role in development, stress responses, and diseases linked to dysregulated proliferation. Validation of NIFK antibodies typically includes knockout controls and functional assays to ensure specificity, given structural similarities among nucleolar proteins.
×
